Literature DB >> 15066604

Biological predictors of change in functioning in the Whitehall II study.

Meena Kumari1, Teresa Seeman, Michael Marmot.   

Abstract

PURPOSE: To examine whether risk factors for CHD are related to change in functioning independent of the presence or development of disease.
METHODS: Longitudinal follow up of 4768 men and 2034 women civil servants from 20 London-based departments with complete data for the SF-36, biological variables, and BMI and health related behaviors. Data are used from two phases of the Whitehall II study, phase 3 (1991-1993) and phase 4 (1995) with an interval of 36 months. Weight, height, fasting insulin, 2-hour post load glucose, total and HDL-cholesterol, fibrinogen, von Willebrand factor, diastolic and systolic blood pressure, and waist hip ratio were measured at phase 3. Demographic and socio-economic information, health related behaviors, and the SF-36 were obtained at both phases by questionnaire.
RESULTS: Waist hip ratio, fasting insulin, triglycerides, and HDL-cholesterol were associated with a decline in physical functioning in the total cohort and when those with poor health at baseline were removed from the analyses. Principal component analysis revealed that these variables clustered with total cholesterol and may represent insulin resistance. The biological variables had a cumulative effect on decline in physical functioning such that those with poor waist hip ratio, fasting insulin, triglycerides, and HDL-cholesterol was two times greater than those without. This relationship was independent of exercise, smoking, and alcohol intake which explained only 17% and 5.4% of the association in men and women, respectively.
CONCLUSIONS: A number of biological variables, which may represent insulin resistance, are associated with decline in physical functioning in men and women independent of prevalent ill health or health related behaviors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066604     DOI: 10.1016/j.annepidem.2003.09.011

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  7 in total

1.  Organizational Justice and Long-term Metabolic Trajectories: A 25-Year Follow-up of the Whitehall II Cohort.

Authors:  Tibor V Varga; Tianwei Xu; Mika Kivimäki; Amar J Mehta; Reiner Rugulies; Naja H Rod
Journal:  J Clin Endocrinol Metab       Date:  2022-01-18       Impact factor: 5.958

2.  The association of cognitive performance with mental health and physical functioning strengthens with age: the Whitehall II cohort study.

Authors:  M Jokela; A Singh-Manoux; J E Ferrie; D Gimeno; T N Akbaraly; M J Shipley; J Head; M Elovainio; M G Marmot; M Kivimäki
Journal:  Psychol Med       Date:  2009-09-01       Impact factor: 7.723

3.  Physical functioning related to C-reactive protein and fibrinogen levels in mid-life women.

Authors:  Kristin Tomey; MaryFran Sowers; Huiyong Zheng; Elizabeth A Jackson
Journal:  Exp Gerontol       Date:  2009-10-09       Impact factor: 4.032

4.  Specific associations of insulin resistance with impaired health-related quality of life in the Hertfordshire Cohort Study.

Authors:  Wolff Schlotz; Phil Ambery; Holly E Syddall; Sarah R Crozier; Avan Aihie Sayer; Cyrus Cooper; David I W Phillips
Journal:  Qual Life Res       Date:  2006-11-08       Impact factor: 4.147

5.  Allostatic load and health in the older population of England: a crossed-lagged analysis.

Authors:  Sanna Read; Emily Grundy
Journal:  Psychosom Med       Date:  2014-09       Impact factor: 4.312

6.  Weight loss is not mandatory for exercise-induced effects on health indices in females with metabolic syndrome.

Authors:  J B Farinha; D L Dos Santos; G Bresciani; L F Bard; F de Mello; S T Stefanello; A A Courtes; Faa Soares
Journal:  Biol Sport       Date:  2015-01-15       Impact factor: 2.806

7.  Factors Affecting Gender Differences in the Association between Health-Related Quality of Life and Metabolic Syndrome Components: Tehran Lipid and Glucose Study.

Authors:  Parisa Amiri; Tina Deihim; Reza Taherian; Mehrdad Karimi; Safoora Gharibzadeh; Mohammad Asghari-Jafarabadi; Niloofar Shiva; Fereidoun Azizi
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.